Stock Events

Abcam 

$23.99
10
+$0.01+0.04% Tuesday 21:00

Statistics

Day High
23.99
Day Low
23.99
52W High
25.32
52W Low
12.48
Volume
7,430,229
Avg. Volume
5,734,542
Mkt Cap
3.65B
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

11SepExpected
Q1 2021
Q2 2021
Q4 2021
Q2 2022
Q3 2022
Q4 2022
Q2 2023
0
0.1
0.21
0.31
Expected EPS
0.1873
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABCM. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap207.95B
Thermo Fisher Scientific offers a wide range of research and diagnostic solutions, directly competing with Abcam's product offerings in antibodies and reagents.
Danaher
DHR
Mkt Cap174.41B
Danaher, through its subsidiaries like Cytiva and Pall Corporation, provides similar life sciences tools and consumables, competing in the biotechnology and research sectors.
Illumina
ILMN
Mkt Cap18.7B
Illumina provides genomic sequencing solutions that are essential for research, competing with Abcam's offerings in the genomics and proteomics space.
Agilent Technologies
A
Mkt Cap38.9B
Agilent Technologies offers a broad range of analytical instruments and reagents, directly competing with Abcam in the life sciences and diagnostics markets.
Bio-Rad Laboratories
BIO
Mkt Cap8.17B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products that overlap with Abcam's portfolio, especially in antibody-based technologies.
Repligen
RGEN
Mkt Cap8.77B
Repligen offers bioprocessing technologies and products that support the development of biologic drugs, competing with Abcam's solutions for drug discovery and development.
Bio-Techne
TECH
Mkt Cap9.76B
Bio-Techne operates in similar markets as Abcam, offering reagents, instruments, and custom manufacturing services for research and diagnostic applications.
Qiagen NV
QGEN
Mkt Cap9.13B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in areas similar to Abcam's.
Mettler-Toledo International
MTD
Mkt Cap25.42B
Mettler-Toledo International offers precision instruments and services for research and development, competing with Abcam in the provision of lab equipment and supplies.
Waters
WAT
Mkt Cap17.56B
Waters Corporation specializes in analytical laboratory instrument and software, competing with Abcam in the life sciences sector, particularly in chromatography and mass spectrometry.

Analyst Ratings

24$Average Price Target
The highest estimate is $24.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

About

Health Technology
Biotechnology
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Alan Hirzel
Employees
1682
Country
US
ISIN
US0003802040
WKN
000A2QFYM

Listings